Bioactivity | Antibacterial agent 138 has excellent antibacterial activity to multi-drug resistant bacteria. Antibacterial agent 138 inhibits bacterial protein synthesis but bacterial cell walls[1]. |
Invitro | Antibacterial agent 138 (化合物 e4) (0.063 μg/mL,24 h) 对 MRSA 和 MRSE 表现出优异的抑制作用[1]。Antibacterial agent 138 对多重耐药菌具有抗菌活性,MICs (0.063-32μg/mL) 比泰妙菌素低 16-64 倍[1]。Antibacterial agent 138 (60 μg/mL, 24 h) 在 HEPG2 和 HEK293 细胞中未显示出细胞毒性迹象[1]。 Cell Viability Assay[1] Cell Line: |
In Vivo | Antibacterial agent 138 (化合物 e4) (2.5-40 mg/kg,i.p.) 在全身多药耐药金黄色葡萄球菌感染小鼠模型中显示出抗菌活性[1]. Animal Model: |
Name | Antibacterial agent 138 |
Formula | C34H52INO4S |
Molar Mass | 697.75 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Yi Y, et al. Novel pyridinium cationic pleuromutilin analogues overcoming bacterial multidrug resistance. Eur J Med Chem. 2023 May 5;251:115269. |